BackTerreno Realty Overview

Terreno Realty Other Current Liabilities

Latest other current liabilities for TRNO: $-120M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$-118.56M
334.17% YoYΔ $-169.19M vs prior year quarter

Peer trimmed avg / median

Loading

Terreno Realty Other Current Liabilities History

Loading

Terreno Realty vs. peers: Other Current Liabilities Comparison

Loading

Terreno Realty Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Terreno Realty (TRNO) FAQ

Terreno Realty posts a other current liabilities of $-120M as of June 2026. That compares with $51M in the prior-year period — down 334.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Terreno Realty's other current liabilities was $51M. The latest reading is $-120M — a 334.2% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Terreno Realty's financial statement story. At $-120M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for TRNO's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Terreno Realty's other metric pages and overview cover the third.

Judging Terreno Realty against Real Estate peers is usually better than using a market-wide rule of thumb. Business models inside Real Estate are more comparable, which makes gaps in other current liabilities easier to interpret. Start with $-120M here, then scan peer and history charts to see if the gap is persistent.